Citation: M. Molinari et al., Palliative strategies for locally advanced unresectable and metastatic pancreatic cancer, SURG CL NA, 81(3), 2001, pp. 651
Authors:
Molinari, M
Ong, A
Farolan, MJ
Helton, WS
Espat, NJ
Citation: M. Molinari et al., Pancreatic heterotopia and other uncommon causes of non-malignant biliary obstruction, SURG ONCOL, 9(3), 2000, pp. 135-142
Citation: T. Babcock et al., Eicosapentaenoic acid (EPA): An antiinflammatory omega-3 fat with potential clinical applications, NUTRITION, 16(11-12), 2000, pp. 1116-1118
Authors:
Espat, NJ
Chamberlain, RS
Sklar, C
Blumgart, LH
Citation: Nj. Espat et al., Hepatic adenoma associated with recombinant human growth hormone therapy in a patient with Turner's syndrome, DIGEST SURG, 17(6), 2000, pp. 640-643
Authors:
Welborn, MB
Oldenburg, HSA
Hess, PJ
Huber, TS
Martin, TD
Rauwerda, JA
Wesdorp, RIC
Espat, NJ
Copeland, EM
Moldawer, LL
Seeger, JM
Citation: Mb. Welborn et al., The relationship between visceral ischemia, proinflammatory cytokines, andorgan injury in patients undergoing thoracoabdominal aortic aneurysm repair, CRIT CARE M, 28(9), 2000, pp. 3191-3197
Citation: Nj. Espat et al., Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass, J AM COLL S, 188(6), 1999, pp. 649-655
Citation: Nj. Espat et Jj. Lewis, The biological significance of failure at the primary site on ultimate survival in soft tissue sarcoma, SEM RAD ONC, 9(4), 1999, pp. 369-377
Citation: Nj. Espat et M. Karpeh, Reconstruction following total gastrectomy: a review and summary of the randomized prospective clinical trials, SURG ONCOL, 7(1-2), 1998, pp. 65-69